Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000835732 | SCV000977539 | benign | not provided | 2018-03-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV000835732 | SCV005269902 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000014699 | SCV000034954 | benign | MDR1 POLYMORPHISM | 2007-01-26 | no assertion criteria provided | literature only | |
Bruce Budowle Laboratory, |
RCV001029504 | SCV001192290 | drug response | Tramadol response | 2018-04-28 | no assertion criteria provided | research | |
Prevention |
RCV003977583 | SCV004798493 | likely benign | ABCB1-related disorder | 2021-07-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |